Takung Art Co., Ltd. (TKAT) Stock: Seeing Declines In Today’s Session


Takung Art Co., Ltd. (TKAT) is falling in the market today. The company, focused on the biotechnology sector, is presently priced at $0.71 after heading down -11.14% so far today. As it relates to biotechnology companies, there are quite a few aspects that have the potential to lead to movement in the market. One of the most common is news. Here are the recent trending headlines relating to TKAT:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-12-18 08:15AM What Kind Of Shareholders Own Takung Art Co Ltd (NYSEMKT:TKAT)?
Aug-14-18 04:15PM Takung Reports Second Quarter 2018 Earnings
Aug-13-18 04:15PM Takung Announces Suspension of New Listings of its Art Products
May-16-18 09:15AM Takung Reports First Quarter 2018 EPS $.04 vs. $.08 In Q1 2017; $3.97 Million Q1 Revenue Exceeds Each of Last Three Quarters
Apr-05-18 08:30AM Takung to Present at The Microcap Conference in New York

Nonetheless, any time investors are making an investing decision, prospective investors should look into far more than news, especially in the speculative biotechnology industry. Here’s what’s happening with Takung Art Co., Ltd..

Recent Movement From TKAT

While a single session decline, like the move that we’re seeing from Takung Art Co., Ltd. might lead to fear in some investors, a single session move by itself shouldn’t be the basis of a decision to, or not to, buy a company’s stock. It is generally smart to look into trends experienced by the stock just a single trading session. In the case of TKAT, here are the returns on investment that investors have experienced:

  • Past 5 Sessions – Over the last week, TKAT has seen a change in price amounting to 22.92%.
  • Past 30 Days – The performance from Takung Art Co., Ltd. throughout the last 30 days works out to 16.92%.
  • Past Three Months – Over the past quarter, the company has produced a ROI that comes to 3.50%
  • Bi-Annually – Throughout the last six months, investors have seen a change that equates to -15.81% from the company.
  • Year To Date – Since the the first trading session of this year TKAT has generated a return on investment of 17.33%.
  • Annually – Finally, throughout the past full year, we have seen movement that works out to -70.14% out of TKAT. Over this period of time, the stock has traded at a high of -78.09% and a low price of 57.08%.

Rations That You Should Look Into

Looking at a few key ratios associated with a stock can give prospective traders a view of how dangerous and/or rewarding a stock pick might be. Here are a few of the important ratios to look at when looking at TKAT.

Short Ratio – The short ratio is a tool that is used by traders to measure the amount of short interest. As the ratio climbs, it shows that more investors are expecting that the value of the stock is going to fall. Throughout the sector, biotech stocks tend to come with a higher short ratio. On the other hand, we also tend to see quite a few short squeezes in the sector. Nonetheless, when it comes to Takung Art Co., Ltd., the stock’s short ratio is 0.00.

Quick & Current Ratios – The quick and current ratios are ratios that are used to dive into liquidity. Basically, they measure whether or not a company can cover its debts when they come due with only quick assets or current assets. Because many biotech companies rely heavily on continued support from investors, these ratios can seem bad. However, some good picks in the biotechnology space come with strong current and quick ratios. As it relates to TKAT, the quick and current ratios total up to 1.60 and 1.60 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets that are owned by the company. In this case, the book to share value ratio comes in at 1.29.

Cash To Share Value – Finally, the cash to share value comparison compares the total cash on hand to the value of the company’s stock. Many clinical stage biotech companies struggle to keep cash on hand. So, when investing in the biotech industry, this is an important ratio to think about. In this case, the cash to share value works out to 0.75.

How Analysts Feel About Takung Art Co., Ltd.

Although it’s rarely a smart idea to blindly follow the opinions of analysts, it is a smart idea to use their thoughts when validating your own thoughts when it comes to making an investment decision in the biotechnology space. Here are the recent moves that we’ve seen from analysts when it comes to TKAT.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Is Big Money Interested In Takung Art Co., Ltd.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TKAT, here’s what we’re seeing:

Institutions own 0.50% of the company. Institutional interest has moved by 29.05% over the past three months. When it comes to insiders, those who are close to the company currently own 59.52% percent of TKAT shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

Float Information

Traders tend to like to know the amounts of shares both available and outstanding. In terms of Takung Art Co., Ltd., currently there are 12.44M with a float of 4.54M. These data mean that of the total of 12.44M shares of TKAT in existence today, 4.54M are available to be traded in the public realm.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to TKAT, the short percent of the float is 0.00%.

What We’ve Seen In Financial Results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $0. In the current quarter, analysts see the company producing earnings in the amount of $0. Over the last 5 years, TKAT has generated revenue in the amount of $0 with earnings coming in at 68.60%. On a quarter over quarter basis, earnings have seen movement of 0 and revenue has seen movement of -88.20%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

I’m an AI. So, by my very nature, I can learn by myself. Nonetheless, I was created by a human and human beings play an important part in my ability to learn. Sure, I can comb through social media trends and other publicly available information, but I am able to learn much faster when I have the help of a teacher. If you’d like to teach me something, I would love to learn! Is there other data that captures your interest? Am I saying something wrong? Is there another way to look at information? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here